| 000 | pam a22 i 4500 | ||
|---|---|---|---|
| 999 |
_c41949 _d41949 |
||
| 001 | AALScienceDirectebook000004 | ||
| 003 | BD-DhAAL | ||
| 005 | 20191205133502.0 | ||
| 006 | m o d | ||
| 007 | cr cnu|||unuuu | ||
| 008 | 181025s2019 enk ob 001 0 eng d | ||
| 016 | 7 |
_a019100549 _2Uk |
|
| 020 | _a0128161833 | ||
| 020 | _a012816381X | ||
| 020 | _a9780128161838 | ||
| 020 | _a9780128163818 | ||
| 035 |
_a(OCoLC)1057893431 _z(OCoLC)1059254007 |
||
| 040 | _aBD-DhAAL | ||
| 050 | 4 | _aRM302.5 | |
| 072 | 7 |
_aMED _x071000 _2bisacsh |
|
| 072 | 7 |
_aMMG _2bicssc |
|
| 082 | 0 | 4 |
_a615.7042 _223 |
| 100 | 1 |
_aNour, Sabrina. _937992 |
|
| 245 | 1 | 0 |
_aPharmacoepidemiology and pharmacovigilance : _bsynergistic tools to better Investigate drug safety / _cSabrina Nour, Gilles Plourde. _h[electronic resource] |
| 260 | 1 |
_aLondon : _bElsevier, _c[2019] |
|
| 260 | 4 | _c�2019 | |
| 300 | _a1 online resource | ||
| 500 | _a<strong>Off-Campus Access:</strong> Athens ID and Password Required | ||
| 500 | _a<strong>On-Campus Access:</strong> No User ID or Password Required | ||
| 504 | _aIncludes bibliographical references and index. | ||
| 506 | _aElectronic access restricted to authorized BRAC University faculty, staff and students | ||
| 520 | _aPharmacoepidemiology and Pharmacovigilance: Synergistic Tools to Better Investigate Drug Safety examines the role of pharmacoepidemiologic studies in drug development and its use as a prevention tool in pharmacovigilance activities. The book introduces the various epidemiologic tools and study designs commonly used for the surveillance of drug-related adverse effects and reviews the strengths and weaknesses of each. Criticisms surrounding pharmacoepidemiologic research and issues that often interfere or complicate the conduct and interpretation of these studies are also explored. Case studies illustrate the passive and active surveillance of adverse drug reactions in clinical situations, covering important pharmacoepidemiologic concepts like health risk management and safety. The book helps pharmaceutical industry groups engaged in drug safety, clinical investigators, medical evaluators and those seeking regulatory approval enhance the safety of the drug development process for all patient populations. | ||
| 538 | _aMode of access: Internet | ||
| 650 | 0 |
_aDrug interactions. _937993 |
|
| 650 | 0 |
_aDrugs _xSide effects. _937994 |
|
| 650 | 0 |
_aPharmacoepidemiology. _937995 |
|
| 650 | 0 |
_aPharmacology. _937996 |
|
| 650 | 7 |
_aDrug interactions. _2fast _937993 |
|
| 650 | 7 |
_aDrugs _xSide effects. _2fast _937994 |
|
| 650 | 7 |
_aMEDICAL _xPharmacology. _2bisacsh _937997 |
|
| 650 | 7 |
_aPharmacoepidemiology. _2fast _937995 |
|
| 650 | 7 |
_aPharmacology. _2fast _937996 |
|
| 655 | 4 |
_aElectronic books. _937998 |
|
| 700 | 1 |
_aPlourde, Gilles. _937999 |
|
| 776 | 0 | 8 |
_iPrint version: _aNour, Sabrina. _tPharmacoepidemiology and pharmacovigilance. _dLondon : Academic Press, [2019] _z0128161833 _z9780128161838 _w(OCoLC)1028226371 |
| 856 | 4 | 0 |
_zFull text available on ScienceDirect _uhttps://www.sciencedirect.com/science/book/9780128161838 |
| 942 |
_2ddc _cEBK |
||